Pergamum Ab

Promore Pharma Ab

Arla Foods Amba

Pharmasurgics in Sweden Ab

Pergasus Ab

Margit Mahlapuu

Christine Dieterich

Alvar Grönberg

Veronika Sjöstrand

Björn Walse

Bo Svenson

Camilla Björn

Veronika Sjostrand

Mattias Munnich

Ulla Svensson

Mattias Münnich

Bo Svensson

Kajsa Ohlson

Alvar Gronberg

Mattias Muennich

Veronika Sjoestrand

Alvar GRÖNBERG

Veronika SJÖSTRAND

The present invention provides a pharmaceutical formulation comprising LL-37 or a pharmaceutically-acceptable salt thereof and one or more pharmaceutically-acceptable diluent or carrier system, for use in a method of treatment of a chronic ulcer wound (such as a hard-to-heal venous leg ulcer or a diabetic foot ulcer), which method comprises:

Treatment of chronic ulcers

The present invention relates to pharmaceutical compositions enhancing the therapeutic effect of biologically active peptides, especially peptides derived from human lactoferrin. The compositions are useful for the treatment and/or prevention of wounds, scars, and post surgical adhesions.

Hyaluronic acid containing compositions for prevention of the formation of post-surgical scars and post-surgical adhesions

The present invention provides a pharmaceutical formulation comprising LL-37 or a pharmaceutically-acceptable salt thereof and one or more pharmaceutically-acceptable diluent or carrier system, for use in a method of treatment of a chronic ulcer wound (such as a hard-to-heal venous leg ulcer or a diabetic foot ulcer), which method comprises: (a) topical application of the formulation to the ulcer; followed by (b) application of a dressing, and wherein the application of the formulation provides for a dose of LL-37 at the wound site that is below about 80 &#x3bc;g of LL-37 applied per cm2 of wound area, and/or below about 26.7 &#x3bc;g of LL-37 applied per cm2 of wound area, per day of treatment.

The present invention relates to new peptides and to use thereof, in particular for treatment and/or prevention of infections, inflammations, pain, wounds, scar and/or tumors.

Synthetic peptides and their use

Human lactoferrin derived peptides and their use

Growing community of inventors

Gothenburg, Sweden

Margit Mahlapuu